Withdrawal Management Guidelines Safe withdrawal management requires precise coordination between buprenorphine therapy and clonazepam tapering to minimize potentially dangerous drug interactions
As 2024 drew to a close, Englands NICE finalised its guidance for Mounjaro, recommending its use in the primary care setting, for treating adults with a body mass index (BMI) 35 kg/m2 and at least one weight-related co-morbidity, alongside a reduced-calorie diet and increased exercise, with no restriction on treatment duration, equating to a total eligible population of 3.4 million patients [5]
The human research is early but the preclinical literature is deep and consistent
Mol Cell 10: 983994 Tu BP, HoSchleyer SC, Travers KJ, Weissman JS (2000) Biochemical basis of oxidative protein folding in the endoplasmic reticulum
This approach has drawbacks
Systematic assessment of plasma biomarkers in spinocerebellar ataxia